Analysts Offer Insights on Healthcare Companies: Agilent (A) and Tenet Healthcare (THC)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Agilent (A – Research Report) and Tenet Healthcare (THC – Research Report) with bullish sentiments.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Agilent (A)
In a report released today, Patrick B Donnelly from Citi maintained a Buy rating on Agilent. The company’s shares closed last Friday at $137.95.
According to TipRanks.com, Donnelly is a 4-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Agilent with a $167.31 average price target, implying a 22.8% upside from current levels. In a report released today, Evercore ISI also upgraded the stock to Buy with a $160.00 price target.
See the top stocks recommended by analysts >>
Tenet Healthcare (THC)
In a report released today, David S Macdonald from Truist Financial reiterated a Buy rating on Tenet Healthcare, with a price target of $240.00. The company’s shares closed last Friday at $199.45.
According to TipRanks.com, Macdonald is a 5-star analyst with an average return of
Tenet Healthcare has an analyst consensus of Strong Buy, with a price target consensus of $238.24.
